References
US Census Bureau. 2019 Population Estimates by Age, Sex, Race and Hispanic Origin. Census.gov. Accessed October 29, 2021. https://www.census.gov/newsroom/press-kits/2020/population-estimates-detailed.html.
American Cancer Society. Cancer Facts & Figures for Hispanic and Latino People. American Cancer Society. Accessed November 15, 2021. https://www.cancer.org/research/cancer-facts-statistics/hispanics-latinos-facts-figures.html
Weinick RM, Jacobs EA, Stone LC, Ortega AN, Burstin H. Hispanic healthcare disparities: challenging the myth of a monolithic Hispanic population. Med Care. 2004;42(4):313–20. https://doi.org/10.1097/01.mlr.0000118705.27241.7c.
Ramirez AG, Talavera GA, Villarreal R, et al. Breast cancer screening in regional Hispanic populations. Health Educ Res. 2000;15(5):559–68. https://doi.org/10.1093/her/15.5.559.
LaVeist-Ramos TA, Galarraga J, Thorpe RJ, Bell CN, Austin CJ. Are black Hispanics black or Hispanic? Exploring disparities at the intersection of race and ethnicity. J Epidemiol Community Health. 2012;66(7):e21. https://doi.org/10.1136/jech.2009.103879.
Swami N, Baez YA, Franco I, et al. Localized prostate cancer disparities in risk group at presentation and access to treatment for Hispanic men. Prostate Cancer Prostatic Dis. 2022;2022:1–8. https://doi.org/10.1038/s41391-022-00526-5.
Swami N, Nguyen T, Dee EC, et al. Disparities in primary breast cancer stage at presentation among Hispanic subgroups. Ann Surg Oncol. 2022. https://doi.org/10.1245/s10434-022-12302-9.
Jain B, Ng K, Santos PMG, et al. Prostate cancer disparities in risk group at presentation and access to treatment for Asian Americans, Native Hawaiians, and Pacific Islanders: a study with disaggregated ethnic groups. JCO Oncol Pract. 2021. https://doi.org/10.1200/OP.21.00412.
Taparra K, Dee EC, Dao D, Patel R, Santos P, Chino F. Disaggregation of Asian American and Pacific Islander women with Stage 0-II breast cancer unmasks disparities in survival and surgery-to-radiation intervals: a National Cancer Database Analysis From 2004 to 2017. JCO Oncol Pract. 2022. https://doi.org/10.1200/OP.22.00001.
Funding
Dr. Mahal is funded by the Prostate Cancer Foundation and (PCF), the American Society for Radiation Oncology (ASTRO), the Department of Defense, and the Sylvester Comprehensive Cancer Center. Dr. Chino and Dr. Dee are funded in part through the NIH/NCI Support Grant P30 CA008748. Dr. Franco is funded in part through a NIH/NCI Diversity Supplement from the Center to Reduce Cancer Health Disparities 5R01CA240582-03, and a Career Development Award from the Center for Diversity and Inclusion of the Brigham and Women’s Hospital.
Author information
Authors and Affiliations
Contributions
Mr. Swami, Dr. Dee, and Dr. Chino had final responsibility for the decision to submit this article for publication. Concept and Design: all authors; Drafting and Critical revision for important intellectual content: all authors.
Corresponding author
Ethics declarations
Disclosures
Dr. Duma has provided Consulting/Advisory services for Pfizer, Merck, BMS, AstraZeneca, Neogenomics, and Janssen.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Swami, N., Dee, E.C., Franco, I. et al. ASO Author Reflections: The Need for Disaggregated Study among Hispanic Populations. Ann Surg Oncol 29, 7988–7989 (2022). https://doi.org/10.1245/s10434-022-12332-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-022-12332-3